Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
Guía de Práctica Clínica sobre Diabetes tipo 2 - Euskadi.net
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
150. Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, et<br />
al. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular<br />
Events Randomized Trial (FACET) in patients with hypertension<br />
and NIDDM. [see comments.]. <strong>Diabetes</strong> Care. 1998;21(4):597-603.<br />
151. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier<br />
RW. The effect of nisoldipine as compared with enalapril on cardiovascular<br />
outcomes in patients with non-insulin-<strong>de</strong>pen<strong>de</strong>nt diabetes and<br />
hypertension. [see comments.]. New England Journal of Medicine.<br />
1998;338(10):645-52.<br />
152. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, <strong>de</strong> Faire<br />
U, et al. Cardiovascular morbidity and mortality in patients with diabetes<br />
in the Losartan Intervention For Endpoint reduction in hypertension<br />
study (LIFE): a randomised trial against atenolol. Lancet.<br />
2002;359(9311):1004-10.<br />
153. Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie<br />
LH, et al. Beta-blockers for hypertension. Cochrane Database Syst<br />
Rev. 2007;(1):CD002003.<br />
154. ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland<br />
Schumacher H, Dagenais G, Sleight P, An<strong>de</strong>rson C. Telmisartan,<br />
ramipril or both in patients at high risk for vascular events. N engl J<br />
Med. 2008;358(15):1547-59.<br />
155. Effects of ramipril on cardiovascular and microvascular outcomes in<br />
people with diabetes mellitus: results of the HOPE study and MICRO-<br />
HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.<br />
Lancet. 2000;355(9200):253-9.<br />
156. Strippoli G, Craig M, Craig J. Antihypertensive agents for preventing<br />
diabetic kidney disease. Cochrane Database Syst Rev. 2005;4:<br />
CD004136.<br />
157. Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani<br />
AD, et al. Effect of inhibitors of the renin-angiotensin system and<br />
other antihypertensive drugs on renal outcomes: systematic review and<br />
meta-analysis. The Lancet. 366(9502):2026-33.<br />
158. NICE. Clinical Gui<strong>de</strong>line. Management of type 2 diabetes: Retinopathy,<br />
screening and early management. London: National Institute for<br />
Clinical Excellence; 2002.<br />
159. Harper CA, Livingston PM, Wood C, Jin C, Lee SJ, Keeffe JE, et al.<br />
Screening for diabetic retinopathy using a non-mydriatic retinal camera<br />
in rural Victoria. Aust N Z J Ophthalmol. 1998;26(2):117-21.<br />
GUÍA DE PRÁCTICA CLÍNICA SOBRE DIABETES TIPO 2 143
Change language